Printer Friendly
The Free Library
19,595,263 articles and books
Member login
User name  
Password 
 
Join us Forgot password?

American Society of Nephrology Supports First International Symposium on Albuminuria.


Business Editors/Health/Medical Writers

WASHINGTON--(BUSINESS WIRE)--Feb. 12, 2004

World Renowned Experts Gather to Discuss the Importance of the

Protein Albumin in Disease Detection

The American Society of Nephrology (ASN (1) (Autonomous System Number) A unique identifier of an autonomous system on the Internet. Of the 65 thousand ASNs available, more than 30 thousand have been assigned to ISPs and NSPs. ISPs usually have only one ASN, but NSPs may have more than one. ) announced today that the Society supports the First International Symposium on Albuminuria albuminuria /al·bu·min·uria/ (al-bu?mi-nu´re-ah) presence in the urine of serum albumin, the most common kind of proteinuria.albuminu´ric

al·bu·mi·nu·ri·a
n.
. The three day event, titled "The Role Of Albuminuria In Health And Disease: Predicting Outcomes And Targets For Therapy," will be held in New York City New York City: see New York, city.
New York City

City (pop., 2000: 8,008,278), southeastern New York, at the mouth of the Hudson River. The largest city in the U.S.
 in May, and will offer an opportunity for thought leaders from around the world to discuss the role of albuminuria as an independent marker and therapy target for early detection and prevention of kidney and cardiovascular disease. The plans are for more than 100 members of the international medical community to attend. The ASN is a non-profit corporation directed at enhancing knowledge in the mechanisms and treatment of kidney diseases and related disorders. This event will be organized by the National Kidney Foundation Not to be confused with American Kidney Fund.

The National Kidney Foundation, Inc. (NKF) is a major voluntary health organization in the United States. Its mission is to prevent kidney and urinary tract diseases, improve the health and well-being of individuals and
 in association with the International Society of Nephrology, and is made possible by an unrestricted educational grant by AusAm Biotechnologies, Inc.

"A growing body of clinical evidence is proving the significance of testing urine for albuminuria, a precursor to early stage kidney or cardiovascular disease. Our goal in supporting this event is to provide our members with the most up to date clinical findings that will help them diagnose patients who may be at-risk," said Karen Campbell, PhD, Executive Director of the American Society of Nephrology. "We hope that this Symposium will allow for the most prominent clinical and research professionals in this field to exchange important scientific information which will result in helping hundreds of thousands of patients worldwide."

More than 300,000 Americans today have End-Stage Renal Disease End-stage renal disease (ESRD)
Total kidney failure; chronic kidney failure is diagnosed as ESRD when kidney function falls to 5-10% of capacity.

Mentioned in: Chronic Kidney Failure

end-stage renal disease 
 (ESRD ESRD end-stage renal disease.
ESRD
End-stage renal disease; chronic or permanent kidney failure.

Mentioned in: Dialysis, Kidney

ESRD End-stage renal disease, see there
), or total kidney failure, and are dependent on artificial dialysis to stay alive. Diabetes accounts for more than 40 percent of all new cases of ESRD. Studies show that if detected in its initial stages, severe kidney disease can be slowed, halted and in some cases reversed with common drug therapies. A growing body of evidence has confirmed that a high level of albumin is a potential warning sign of the initial stages of the disease. Diabetes is the leading cause of kidney failure in the U.S., and patients with diabetes are at an increased risk of kidney and cardiovascular disease.

"Early detection of higher than normal levels of urinary albumin is not only indicative of a risk for kidney and cardiovascular disease, but also appears to indicate a need for preventative treatment," said Dr. Dick de Zeeuw, Professor and Head of the Department of Clinical Pharmacology of the University of Groningen Degree programmes
Bachelor's degree programmes
The Bachelor phase lasts three years and after successful completion of a Bachelor's programme result in a BSc or BA degree. There are a total number of 61 Bachelor degree programmes.
 in The Netherlands and the Symposium's Chairman. "The conference is aiming to obtain an understanding of the current status of this topic by the joint input of many experts in this field."

In addition to the ASN, the symposium is supported by the Juvenile Diabetes Research Foundation The Juvenile Diabetes Research Foundation (JDRF) is the leading charitable funder and advocate of type 1 (juvenile) diabetes research worldwide. The mission of JDRF is to find a cure for diabetes and its complications through the support of research. , the American Diabetes Association The American Diabetes Association, or the ADA, is an American health organization providing diabetes research, information and advocacy. Founded in 1940, the American Diabetes Association conducts programs in all 50 states and the District of Columbia, reaching hundreds of  and the American Heart Association American Heart Association (AHA),
n.pr a national voluntary health agency that has the goal of increasing public and medical awareness of cardiovascular diseases and stroke, and thereby reducing the number of associated deaths and disabilities.
.

About the American Society of Nephrology

The American Society of Nephrology (ASN) is a not-for-profit organization of more than 9,000 physicians and scientists from over 83 countries who are dedicated to the study and practice of nephrology. Founded in 1967, ASN was established to enhance and assist the study and practice of nephrology; provide a forum for the promulgation of information regarding the latest research and clinical findings on kidney diseases; and meet the professional and continuing education needs of its members.

About AusAm Biotechnologies, Inc.

AusAm is a biotechnology research and development company commercializing both diagnostic and therapeutics products to identify and treat major diseases. AusAm's recently FDA-cleared diagnostic for the detection of intact albumin in urine is the first direct test to measure a potential indicator of the beginning stages of kidney disease and it is currently offered by several reference laboratories and hospitals in the United States Lists of hospitals for each U.S. state:

  • Alabama
  • Alaska
  • Arizona
  • Arkansas
  • California
  • Colorado
  • Connecticut
  • Delaware
  • Florida
  • Georgia
  • Hawaii
  • Idaho
  • Illinois
  • Indiana
  • Iowa
  • Kansas
  • Kentucky
.
COPYRIGHT 2004 Business Wire
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2004, Gale Group. All rights reserved. Gale Group is a Thomson Corporation Company.

 Reader Opinion

Title:

Comment:



 

Article Details
Printer friendly Cite/link Email Feedback
Publication:Business Wire
Date:Feb 12, 2004
Words:644
Previous Article:Juvenile Diabetes Research Foundation Supports First International Symposium on Albuminuria.
Next Article:Taurus Begins Third Crosscut & Detailed Sampling at Fenelon Gold Project.



Related Articles
TRANSPLANT SURVIVAL, PATIENT'S RACE LINKED?
Calendar.
Annual supplement of abstracts: SMA's 96th Annual Scientific Assembly.
Foreign calendar.
AMGEN DRUG MAY LESSEN THYROID DISORDER.
Calendar.
Calendar.
Continuing education: locating educational resources can be easy--if you know where to look.
Calendar.
FSCT announces Officer and Board nominations; Elections to be held October 26.

Terms of use | Copyright © 2012 Farlex, Inc. | Feedback | For webmasters | Submit articles